| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 32.97B | 31.41B | 21.83B | 20.62B | 20.02B | 22.17B |
| Gross Profit | 11.08B | 11.23B | 5.74B | 5.37B | 4.71B | 5.69B |
| EBITDA | 8.88B | 8.91B | 4.02B | 3.88B | 4.04B | 4.57B |
| Net Income | 2.57B | 2.94B | 651.72M | 666.55M | 275.45M | 758.36M |
Balance Sheet | ||||||
| Total Assets | 81.00B | 81.60B | 30.38B | 26.37B | 28.52B | 28.17B |
| Cash, Cash Equivalents and Short-Term Investments | 24.25B | 29.49B | 5.26B | 4.81B | 5.45B | 4.17B |
| Total Debt | 21.81B | 23.66B | 12.41B | 9.56B | 11.55B | 12.32B |
| Total Liabilities | 51.18B | 51.34B | 21.06B | 17.88B | 20.07B | 20.05B |
| Stockholders Equity | 29.61B | 30.06B | 9.14B | 8.35B | 8.32B | 8.00B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -11.87B | -597.67M | 3.47B | 2.66B | 2.76B |
| Operating Cash Flow | 0.00 | 5.79B | 2.88B | 3.96B | 3.96B | 4.11B |
| Investing Cash Flow | 0.00 | -8.32B | -2.03B | -606.13M | -1.67B | -1.36B |
| Financing Cash Flow | 0.00 | 26.76B | -410.59M | -4.00B | -1.01B | -3.15B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | ¥20.73B | 9.96 | ― | ― | 17.93% | 91.21% | |
68 Neutral | ¥31.01B | 27.58 | ― | 0.39% | 30.59% | 65.14% | |
65 Neutral | ¥10.14B | 13.23 | ― | 2.16% | 2.75% | 25.24% | |
62 Neutral | ¥43.48B | 50.91 | ― | ― | ― | ― | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
61 Neutral | ¥15.78B | 8.71 | ― | ― | ― | ― | |
52 Neutral | ¥105.54B | 367.27 | ― | 0.14% | 36.42% | 28.23% |